Invention Grant
- Patent Title: PDE5 compositions and methods for immunotherapy
-
Application No.: US17649592Application Date: 2022-02-01
-
Publication No.: US11666642B2Publication Date: 2023-06-06
- Inventor: Vipin Suri , Byron Delabarre , Michael N. Gladstone , Celeste Richardson , Brian Dolinski , Abhishek Kulkarni , Mara Christine Inniss , Dexue Sun , Dan Jun Li , Grace Y. Olinger , Scott Francis Heller
- Applicant: Obsidian Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: OBSIDIAN THERAPEUTICS, INC.
- Current Assignee: OBSIDIAN THERAPEUTICS, INC.
- Current Assignee Address: US MA Cambridge
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K38/46
- IPC: A61K38/46 ; A61P35/00 ; A61K31/4985 ; A61K35/17 ; A61K38/17 ; A61K38/20 ; A61K39/395 ; C07K14/54 ; C07K14/725 ; C07K14/705 ; C07K14/715 ; C07K16/28 ; C12N9/16 ; A61K39/00 ; A61P37/04 ; C07K19/00
Abstract:
The present invention relates to compositions and methods for the regulated and controlled expression of proteins. Methods for inducing anti-cancer immune responses in a subject are also provided.
Public/Granted literature
- US20230074330A1 PDE5 COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY Public/Granted day:2023-03-09
Information query
IPC分类:
